… DOACs have stable pharmacokinetics and pharmacodynamics; however, variability in
DOAC response is common and may be attributed to numerous factors, including patient‐specific …

… However, biological differences between the sexes other … Differences in PK, PD, and
pharmacogenomics have been … differences in pharmacokinetics and/or pharmacodynamics. …

… “Depression” references in scientific documents have increased exponentially since 1950, …
into pharmacogenetics in pharmacokinetic studies, considering pharmacogenetics as an …

… scientific gaps and optimize the treatment of hypertension in … However, because the P
value for interaction between … differences between men and women refer to sex differences…

… individuals, explored the interaction between candidate genes and … unexplained
pharmacokinetic/pharmacodynamic variation … are essential for accelerating scientific progress. …

… differences between males and females throughout the nephron. … Disparities may be
related to biological factors as well as … gender and PK as well as pharmacogenetics, that could …

… of biological characteristics that define humans as female or … on their chemical structure,
pharmacokinetic properties of the single … Indeed, there are also pharmacodynamic interactions …

… Historically, pharmacogenetics research focused on its core … Drug–drug interactions
between the antiretrovirals in … provides a genetic basis for this difference between populations. …

… 1 (ABCB1), are associated to differences in pharmacokinetics. The three … , among others,
and several studies found associations between polymorphisms in these genes and variations …

… although pharmacodynamic interactions are the aim of this kind of association, pharmacokinetic
interactions … in the case of biologically potent drugs (growth factors, interferon). Loss of …